Institutional investors purchased a net $93.9 thousand shares of ECTE during the quarter ended September 2014 and now own 27.56% of the total shares outstanding. This is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PLATINUM MANAGEMENT (NEW YORK) L... Bought 55.7 Thousand shares of Echo Therapeutics Inc
GEODE CAPITAL MANAGEMENT LLC Bought 31.6 Thousand shares of Echo Therapeutics Inc